FDA will shorten the review periods for priority generic drugs by two months.
Christine Blank, Contributing Editor
Two recent generic cholesterol-lowering drugs are helping reduce health-care costs.
High court ruling should make biosimilars available faster.
Patients are less like to buy a requested brand name prescription than a generic one.
Good glucose control can help children and teens with type 1 diabetes boost their quality of life.
Interventions by pharmacists can help improve the results of diabetes clinical trials.
Residency programs are teaching young pharmacists how to cope with stress.
Drug makers are starting plans to help patients pay for diabetes drugs.
NCPA sends letter to Senate on prescription issues in health-care reform.
The Nevada law to fight high diabetes drug prices has stumbled.